Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Neurology, Karl-Franzens University
Graz, Austria
- Foothills Hospital
Calgary, Alberta, Canada
- London Health Sciences Centre
London, Ontario, Canada
- the Ottawa Hospital, General Campus - Neurology Division
Ottawa, Ontario, Canada
- Chum Hospital Notre Dame
Montreal, Quebec, Canada
- Fakultni Nemocnice Brno-Bohunice
Brno, Czechia
- St. Anna'S Teaching Hospital
Brno, Czechia
- Department of Neurology, Motol Teaching Hospital
Prague, Czechia
- Všeobecná Fakultní Nemocnice
Prague, Czechia
- Medizinische Einrichtungen Der Heinrich Heine Universitat, Neurologische Klinik
Düsseldorf, Germany
- Helios Klinikum Erfurt Gmbh, Klinik Und Poliklinik Fur Neurologie
Erfurt, Germany
- Klinikum Der Justus-Liebig-Universitat, Zentrum Fur Neurologie Und Neurochirurgie
Giessen, Germany
- Universitatsklinikum Munster, Klinik Und Poliklinik Fur Neurologie
Münster, Germany
- Klinikum Osnabrück Gmbh
Osnabrück, Germany
- Universitatsklinikum Ulm, Poliklinik Fur Neurologie
Ulm, Germany
- Klinijum Der Universitat Wurzburg, Neurologische Klinik Und Poliklinik
Würzburg, Germany
- Henry Dunant Hospital
Athens, Greece
- Jahn Ferenc Delpesti Teaching Hospital
Budapest, Hungary
- Szent Imre Korhaz Neurologia
Budapest, Hungary
- Uzsoki Street Hospital
Budapest, Hungary
- Szeged University of Science
Szeged, Hungary
- Lady Davis Carmel Medical Center
Haifa, Israel
- Katedra I Klinika Neurologii; Slaskiej Akademii Medycznej, Samodzielny Publiczny Centralny Szpital Kliniczny
Katowice-Ligota, Poland
- Katedra I Klinika Neurologii, Univerytetu Medycznego W Lodzi
Lodz, Poland
- Katedra I Klinika Neurologii
Lublin, Poland
- Klinika Neurologiczna, Wojskowy Instut Medyczny
Warsaw, Poland
- Dererova Nemocnica S Poliklinikou Nerologicka Klinika
Bratislava, Slovakia
- Fakultna Menocnica Bratislava
Bratislava, Slovakia
- Lasarette Neurologiavdeling
Lund, Sweden
- Karilinska Sjukhuset
Stockholm, Sweden
- University Hospital, Queens Medical Centre
Nottingham, United Kingdom
- Barrow Neurological Institute at St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Northwest Neurospecialists, Pllc
Tucson, Arizona, United States
- the Mt. Sinai Medical Center, Department of Neurology
New York, New York, United States
- Suny Health Science Center at Stony Brook, Department of Neurology
Stony Brook, New York, United States
- Wake Forest University - School of Medicine
Winston-Salem, North Carolina, United States
- Neurology Health Care Service, Fletcher Allen Health Care
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2002
- Primary completion
- 28 Feb 2005
- Completion
- 28 Feb 2005
- Last update posted
- 27 Apr 2016
- Registered enrollment
- 128
- Registry id
- NCT00220779
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.